A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging (DEMAGUS)

July 10, 2025 updated by: Hospices Civils de Lyon

Towards a New Generation of Magnetoencephalographs: Evaluation of the FYNA Research (Mag4Health 48 Sensors MEG's Name) System (Full-head Magnetoencephalographs System With Optically Pumped Magnetometers)

The goal is to perform a first evaluation of the capabilities of a new generation of non-invasive magnetoencephalography whole head device using optically pumped magnetometers using Helium 4 as the sensitive element (OPM He4) to record brain magnetic activities. The investigators will record 1) healthy subjects stimulated with visual, auditory, somesthesic and motor stimuli and 2) athletes who suffered a mild concussion. The main hypothesis is that the OPM magnetoencephalographs (MEG) system will be able to detect brain activity. The secondary hypothesis is that the data recorded with the OPM MEG system will allow to reconstruct maps of the brain activity. To test the main hypothesis, they will compare the signal to noise ratio of brain activities between a classical MEG system and the new OPM He4 MEG. The secondary hypothesis will be tested through a comparison of the maps of brain activity obtained thanks to the data recorded with a classical MEG system and the new OPM He4 MEG.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, 69677
        • Recruiting
        • Service de Neurologie Fonctionnelle et d'Epileptologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon
        • Contact:
      • Lyon, France, 69008
        • Not yet recruiting
        • Centre Orthopédique Paul Santy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Healthy volunteers:

Inclusion Criteria:

  • Age 18 to 70
  • Strongly motivated to participate to the study
  • Signed informed consent for the study

Exclusion Criteria:

  • major cognitive deficit and unable to understand the instructions
  • previous neurology or psychiatric or sleep pathologies
  • Woman with a positive pregnancy test during the inclusion.
  • Subjects under guardianship, curatorship or safeguard of justice protection
  • Subjects deprived of their liberty
  • Subject not affiliated to a social security system.
  • Subject with common contraindications to MEG and MRI examination :

    • Metal in the body incompatible with performance of the examination (pacemaker, implantable pump, neurostimulator, cochlear implant, auditory prothesis, metalic prothesis, intracerebral clip, implantable defibrillator, any metalic parts in the brain or upper part of the body, ventriculoperitoneal valve, dental appliance or steel pivot for root canal, ferromagnetic foreign body in the upper part of the upper part of the body)
    • Claustrophobia

Subjects who suffered a mild concussion:

Inclusion Criteria:

  • Male aged from 18 to 40
  • Strongly motivated to participate to the study
  • Signed informed consent for the study
  • Mild concussion confirmed by the club doctor and a neurologist neurologist in the three weeks preceding the experiment

Exclusion Criteria:

  • major cognitive deficit and unability to understand the instructions
  • previous neurology or psychiatric or sleep pathologies except mild concussion
  • Woman with a positive pregnancy test during the inclusion.
  • Subjects under guardianship, curatorship or safeguard of justice protection
  • Subjects deprived of their liberty
  • Subject not affiliated to a social security system
  • Subject with common contraindications to MEG and MRI examination :

    • Metal in the body incompatible with performance of the examination (pacemaker, implantable pump, neurostimulator, cochlear implant, auditory prothesis, metalic prothesis, intracerebral clip, implantable defibrillator, any metalic parts in the brain or upper part of the body, ventriculoperitoneal valve, dental appliance or steel pivot for root canal, ferromagnetic foreign body in the upper part of the upper part of the body)
    • Claustrophobia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy subjects
Healthy volunteers aged between 18 and 70 years, without neurological or psychiatric or sleep disorders
We will use the FYNA Research system on 20 healthy volunteers with a visual and auditory attention task to evaluate the system's performance in recording brain signals complex frequency content.
We will use the FYNA Research system on 20 healthy healthy volunteers with a language production task to assess the system's functional mapping capabilities and a resting task to assess the system's ability to identify resting networks.
We will use the FYNA Research system in 20 healthy volunteers with a visuo-motor task to evaluate the system's performance in recording brain signals when the subject moves, inducing perturbations that affect the classical system (loss of spatial precision) and the FYNA Research system (low-frequency artifacts).
Experimental: Subjects with concussion
Male athletes volunteers with concussion aged between 18 and 40 years, without neurological or psychiatric or sleep disorders other than cerebral concussion.
We will be using the FYNA Research system on 20 concussed male athletes volunteers to assess the system's ability to detect modulations in the frequency content of resting brain activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Signal to Noise Ratio comparison between classical MEG and FYNA Research for the visual stimulations
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

The signal to noise ratio of normal (SNR) brain activity following a visual stimulus will be computed with respect to the pre-stimulus baseline -100 milliseconds to -10 milliseconds.

We will compare the SNRs obtained with the classical MEG system serving as a reference and the SNRs obtained with the new OPM He4 MEG through the group of healthy volunteers for this given stimulus.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).
Signal to Noise Ratio comparison between classical MEG and FYNA Research for the auditory stimulations
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

The signal to noise ratio of normal (SNR) brain activity following an auditory stimulus will be computed with respect to the pre-stimulus baseline -100 milliseconds to -10 milliseconds .

We will compare the SNRs obtained with the classical MEG system serving as a reference and the SNRs obtained with the new OPM He4 MEG through the group of healthy volunteers for this given stimulus.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).
Signal to Noise Ratio comparison between classical MEG and FYNA Research for the somesthesia stimulations
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

The signal to noise ratio of normal (SNR) brain activity following a somesthetic stimulus will be computed with respect to the pre-stimulus baseline -100 milliseconds to -10 milliseconds .

We will compare the SNRs obtained with the classical MEG system serving as a reference and the SNRs obtained with the new OPM He4 MEG through the group of healthy volunteers for this given stimulus.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).
Signal to Noise Ratio comparison between classical MEG and FYNA Research for the motor stimulations
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

The signal to noise ratio of normal (SNR) brain activity following a motor stimulus will be computed with respect to the pre-stimulus baseline -100 milliseconds to -10 milliseconds .

We will compare the SNRs obtained with the classical MEG system serving as a reference and the SNRs obtained with the new OPM He4 MEG through the group of healthy volunteers for this given stimulus.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).
Signal to Noise Ratio comparison between classical MEG and FYNA Research for the rest activity
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

The signal to noise ratio of normal (SNR) brain activity at rest will be computed with respect to the pre-stimulus baseline -100 milliseconds to -10 milliseconds .

We will compare the SNRs obtained with the classical MEG system serving as a reference and the SNRs obtained with the new OPM He4 MEG through the group of male athletes with concussion.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of maps of brain activity
Time Frame: Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).

We will report the spatial correlation between the maps computed with the classical MEG system and the ones computed with the new OPM He4 MEG. The classical MEG will serve as a reference.

Healthy volunteers solely.

Visit 2 (during the intervention, scheduled from 1 to 30 days from inclusion visit V1).
Evaluation of the comfort of the subject during the optically pumped magnetometers (OPM) He4 MEG recordings through a short verbal questionnaire (scores of the absolute and relative comfort scales).
Time Frame: 5 minutes after the end the recording session
The evaluation will be done verbally through a short questionnaire. This questionnaire evaluates the overall comfort of the OPM system with two questions: 1) An evaluation of the overall comfort thanks to a scale with five steps from very uncomfortable to very comfortable and 2) A comparison with the classical MEG system thanks to a 5 steps scale from much less comfortable than the classical MEG system to much more comfortable.
5 minutes after the end the recording session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julien JUNG, MD, Service d'Epilepsie et Explorations fonctionnelles neurologiques,Hôpital Neurologique P. Wertheimer, Groupement Hospitalier Est, HCL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 9, 2025

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

January 5, 2024

First Submitted That Met QC Criteria

February 2, 2024

First Posted (Actual)

February 6, 2024

Study Record Updates

Last Update Posted (Actual)

July 15, 2025

Last Update Submitted That Met QC Criteria

July 10, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Experiment 1: visual and auditory attention task

Subscribe